Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Merck Gets First FDA Approval of Keytruda
Merck wins first FDA approval for Keytruda as a treatment for mesothelioma
Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug Keytruda as a treatment for malignant plural mesothelioma, a rare cancer associated with asbestos.
Merck's Keytruda Obtains its First FDA Approval for Mesothelioma
Merck & Co., Inc. MRK announced that the FDA had approved its blockbuster anti-PD-1 therapy, Keytruda (pembrolizumab), for a new indication. The regulatory body has now approved Keytruda in combination with pemetrexed and platinum chemotherapy for the first-line treatment of adult patients with unresectable advanced or metastatic malignant pleural mesothelioma (MPM).
Keytruda Plus Chemotherapy Approved for Malignant Pleural Mesothelioma
The FDA has approved Keytruda in combination with pemetrexed and platinum chemotherapy, as first-line Tx of unresectable advanced or metastatic malignant pleural mesothelioma.
USFDA nod to Merck KEYTRUDA plus Pemetrexed, Platinum Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S.Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination
Merck Gets First FDA Approval of Keytruda in Malignant Pleural Mesothelioma
Merck & Co. has won its first U.S. approval for use of its blockbuster cancer drug Keytruda in patients with malignant pleural mesothelioma, a rare cancer that grows in the membrane that lines the walls of the chest and lungs.
FDA Approves Keytruda Plus Chemo for Pleural Mesothelioma Subset
Keytruda plus chemo has been approved for unresectable advanced or metastatic malignant pleural mesothelioma based on findings from the KEYNOTE-483 trial.
Pembrolizumab Approved With Chemotherapy for Malignant Pleural Mesothelioma
Pembrolizumab (Keytruda, Merck) has picked up another indication — this time for the first-line treatment of unresectable advanced or metastatic malignant pleural mesothelioma (MPM) in combination with pemetrexed and platinum chemotherapy.
Merck's Keytruda Obtains its First FDA Approval for Mesothelioma
Pleural
mesothelioma
is a type of cancer which develops in the tissue that lines the lungs or pleura. This is the first time
Keytruda
has been approved for the given indication in the United States.
Merck: KEYTRUDA Plus Chemotherapy Gets FDA Approval For Malignant Pleural Mesothelioma In Adults
Drug major Merck & Co., Inc. (MRK) announced Wednesday that the U.S. Food and Drug Administration has approved its anti-PD-1 therapy
Merck wins first FDA approval for Keytruda as a treatment for mesothelioma
Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug
Keytruda
as a treatment for malignant plural
mesothelioma
, a rare cancer associated ...
Monthly Prescribing Reference
7d
Keytruda Plus Chemotherapy Approved for Malignant Pleural Mesothelioma
The Food and Drug Administration (FDA) has approved
Keytruda
® (pembrolizumab ... unresectable advanced or metastatic malignant pleural
mesothelioma
(MPM). The approval was supported by data ...
1h
Merck fails in late-stage trial for Keytruda combo in colon cancer
Merck (MRK) stock is in focus as a Phase 3 trial for its cancer drug Keytruda in colorectal cancer patients did not meet ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Would-be assassin charged
Penn suspends law professor
Campaign office damaged
Chemical leak in OH county
US to waive visas for Qatar
Calls strike against 'LoL’
Texas AG appeal denied
Briefed on Iranian threats
InfoWars to be auctioned off
Woman dies in 'suicide pod’
China conducts ICBM test
Gets 2-yrs for role in fraud
NYC schools boss retiring
Pac-12 sues Mountain West
Johnny Cash statue unveiled
‘Trump Train’ jury verdict
ISR: Hezbollah leader killed
X account hacked
Rioter mistakenly released
Food packaging cancer risk
Union gets more voting time
$375M military aid to UKR
NC sending absentee ballots
Executed by lethal injection
EEOC blocked on rules
Dali owner, operator sued
PA county ballot ruling
Severe obesity on the rise
Recalls 41K+ motorcycles
Related topics
Merck & Co.
Food and Drug Administration
Pembrolizumab
Feedback